Farzaneh Montazerifar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farzaneh Montazerifar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Mansour Karajibani
Health Promotion Research Center, Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
7 shared publications - Alireza Dashipour
Department of Food Science & Technology, School of Medicine Zahedan University of Medical Sciences Zahedan Iran
3 shared publications Razieh Hosseini
Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
2 shared publicationsAhmad Bolouri
Department of Cardiology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
1 shared publication- Ahmad Bolouri
Department of Cardiology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
1 shared publication - Ali Mokhtari
Department of Neurosurgery, Shahr-e-kord University of Medical Sciences, Shahr-e-Kord, Iran
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (9) , e20231638
The association of ghrelin rs26311 and rs27647 polymorphisms and mRNA expression with preeclampsia susceptibility and severity—A case–control study
Ghrelin is an adipokine the placenta generates to control the maternal metabolic adaptation to pregnancy. It causes different pregnancy complications like preeclampsia (PE). Therefore, the aim of this study was to assess the association between ghrelin mRNA expression and rs26311 and rs27647 polymorphisms and PE development.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (9) , e20231638
Open AccessThe association of ghrelin rs26311 and rs27647 polymorphisms and mRNA expression with preeclampsia susceptibility and severity—A case–control study
Ghrelin is an adipokine the placenta generates to control the maternal metabolic adaptation to pregnancy. It causes different pregnancy complications like preeclampsia (PE). Therefore, the aim of this study was to assess the association between ghrelin mRNA expression and rs26311 and rs27647 polymorphisms and PE development.
- Open Access
- 13 May 2023
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 25 (2)
Association of Serum Zinc Levels and Some Risk Factors with Gestational Diabetes Mellitus in Women Referred to the Diabetes Clinic of Bu-Ali Hospital of Zahedan in 2021
Background: Diabetes is the most common medical complication of pregnancy. Low serum zinc levels in pregnant women can cause uterine growth restriction and increase the risk of abortion and neural tube defects. Objectives: This study was designed to evaluate the association of serum zinc levels with gestational diabetes (GDM) in diabetic and healthy pregnant women referred to Bu-Ali Hospital in Zahedan. Methods: This case-control study was performed on 70 pregnant women, including 35 diabetics and 35 healthy subjects, referred to our diabetes clinic. The subjects were enrolled based on inclusion and exclusion criteria. Demographic, clinical, and obstetric characteristics of the subjects were gathered, and a diabetes screening test was performed for all of them. Then 3 mL of blood was taken from each person to determine serum zinc level by a calorimetric method. Statistical analysis using SPSS software was 16. Results: The means of serum zinc level in pregnant women with GDM and healthy pregnant women were 62.22 ± 5.57 and 89.17 ± 12.16 g /dL, respectively (P = 0.001). Except for the mean values of fasting, 1-hour, and 2-hour blood sugar levels (P = 0.001), there was no significant difference between diabetic and non-diabetic women in terms of age, weight, gestational age, number of deliveries, number of abortions, and body mass index. Conclusions: Our results indicated that most of the pregnant women had severe zinc deficiency, which could intensify pregnancy complications, boosting the risk of pregnancy complications for mothers and neonates. Therefore, screening for gestational diabetes and zinc deficiency and their treatment are recommended to improve pregnancy outcomes.
- 13 May 2023
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 25 (2)
Open AccessAssociation of Serum Zinc Levels and Some Risk Factors with Gestational Diabetes Mellitus in Women Referred to the Diabetes Clinic of Bu-Ali Hospital of Zahedan in 2021
Background: Diabetes is the most common medical complication of pregnancy. Low serum zinc levels in pregnant women can cause uterine growth restriction and increase the risk of abortion and neural tube defects. Objectives: This study was designed to evaluate the association of serum zinc levels with gestational diabetes (GDM) in diabetic and healthy pregnant women referred to Bu-Ali Hospital in Zahedan. Methods: This case-control study was performed on 70 pregnant women, including 35 diabetics and 35 healthy subjects, referred to our diabetes clinic. The subjects were enrolled based on inclusion and exclusion criteria. Demographic, clinical, and obstetric characteristics of the subjects were gathered, and a diabetes screening test was performed for all of them. Then 3 mL of blood was taken from each person to determine serum zinc level by a calorimetric method. Statistical analysis using SPSS software was 16. Results: The means of serum zinc level in pregnant women with GDM and healthy pregnant women were 62.22 ± 5.57 and 89.17 ± 12.16 g /dL, respectively (P = 0.001). Except for the mean values of fasting, 1-hour, and 2-hour blood sugar levels (P = 0.001), there was no significant difference between diabetic and non-diabetic women in terms of age, weight, gestational age, number of deliveries, number of abortions, and body mass index. Conclusions: Our results indicated that most of the pregnant women had severe zinc deficiency, which could intensify pregnancy complications, boosting the risk of pregnancy complications for mothers and neonates. Therefore, screening for gestational diabetes and zinc deficiency and their treatment are recommended to improve pregnancy outcomes.
- Open Access
- 30 October 2022
- Published by Knowledge E DMCC in Journal of Nutrition and Food Security
The Relationship between Serum Levels of Irisin with Cardiometabolic Biomarkers in Patients with Type 2 Diabetes
Background: Diabetes and obesity are associated with an increased risk of cardiovascular disease. Irisin is a newly recognized peptidic myokine with anti-obesity and anti-diabetic properties. This study aims to investigate the relationship between serum irisin levels with cardiometabolic biomarkers in patients with type 2 diabetes mellitus (T2DM). Methods: In this comparative cross- sectional study, 80 T2DM patients and 80 control participants (adjusted by age, body mass index (BMI), and physical activity) referring to Bou Ali Hospital in Zahedan, Iran, were enrolled. Serum irisin concentrations, anthropometric, and biochemical parameters were assessed. Results: Serum irisin level was significantly lower in T2DM patients compared to control group. Multiple linear regression analysis revealed that after adjustment for age, irisin was negatively associated with waist circumference (WC, P < 0.01) and waist to height ratio (WHtR, P < 0.01), homeostasis model assessment insulin resistance (HOMA-IR, P = 0.009), triglycerides (TG, P = 0.016), and positively associated with high density lipoprotein cholesterol (HDL-c, P = 0.03) in diabetic patients. Conclusion: The findings suggest that irisin can be used as a marker for predicting of obesity-related cardiometabolic biomarkers, insulin resistance, and incidentT2DM.
- 30 October 2022
- Published by Knowledge E DMCC in Journal of Nutrition and Food Security
Open AccessThe Relationship between Serum Levels of Irisin with Cardiometabolic Biomarkers in Patients with Type 2 Diabetes
Background: Diabetes and obesity are associated with an increased risk of cardiovascular disease. Irisin is a newly recognized peptidic myokine with anti-obesity and anti-diabetic properties. This study aims to investigate the relationship between serum irisin levels with cardiometabolic biomarkers in patients with type 2 diabetes mellitus (T2DM). Methods: In this comparative cross- sectional study, 80 T2DM patients and 80 control participants (adjusted by age, body mass index (BMI), and physical activity) referring to Bou Ali Hospital in Zahedan, Iran, were enrolled. Serum irisin concentrations, anthropometric, and biochemical parameters were assessed. Results: Serum irisin level was significantly lower in T2DM patients compared to control group. Multiple linear regression analysis revealed that after adjustment for age, irisin was negatively associated with waist circumference (WC, P < 0.01) and waist to height ratio (WHtR, P < 0.01), homeostasis model assessment insulin resistance (HOMA-IR, P = 0.009), triglycerides (TG, P = 0.016), and positively associated with high density lipoprotein cholesterol (HDL-c, P = 0.03) in diabetic patients. Conclusion: The findings suggest that irisin can be used as a marker for predicting of obesity-related cardiometabolic biomarkers, insulin resistance, and incidentT2DM.
- Open Access
- 14 May 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (1) , 743-750
The impact of zinc supplementation on galectin-3 and metabolic markers in diabetic patients on hemodialysis: A randomized, double-blind, placebo-controlled trial
Purpose There is little information about the association between zinc sulfate (ZnSO4) supplementation and metabolic profiles in zinc-deficient diabetic patients on hemodialysis (DHPs). Therefore, we aimed to investigate the association between ZnSO4 supplementation and serum levels of galectin-3 (Gal-3) and cardiometabolic parameters in zinc-deficient DHPs. Methods In the present randomized double-blind placebo-controlled clinical trial, 46 zinc-deficient DHPs (35–62 years) were included and assigned to receive either 220 mg/d ZnSO4 or placebo for 8 weeks. Serum levels of Gal-3, lipid profile, and blood pressure (BP) were assessed at baseline and the end of trial. Results We found a significant effect of ZnSO4 intake on the reduction of serum Gal-3 (P = < 0.001), triglycerides (P = < 0.001), total cholesterol (P = < 0.001), low-density lipoprotein cholesterol (P = < 0.001) and increased high-density lipoprotein cholesterol (P = < 0.001) as compared to the control group. Additionally, systolic blood pressure (SBP) (P = 0.006) and diastolic blood pressure (DBP) (P = 0.01) were significantly reduced following 8 weeks of ZnSO4 supplementation. Conclusion Taken together, 220 mg ZnSO4 supplementation per day for 8 weeks among zinc-deficient DHPs had beneficial effects on Gal-3 and metabolic profiles. Iranian Registry of Clinical Trials Identifier IRCT20191217045765N1, date of registration: 2020–02-09.
- 14 May 2022
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (1) , 743-750
Open AccessThe impact of zinc supplementation on galectin-3 and metabolic markers in diabetic patients on hemodialysis: A randomized, double-blind, placebo-controlled trial
Purpose There is little information about the association between zinc sulfate (ZnSO4) supplementation and metabolic profiles in zinc-deficient diabetic patients on hemodialysis (DHPs). Therefore, we aimed to investigate the association between ZnSO4 supplementation and serum levels of galectin-3 (Gal-3) and cardiometabolic parameters in zinc-deficient DHPs. Methods In the present randomized double-blind placebo-controlled clinical trial, 46 zinc-deficient DHPs (35–62 years) were included and assigned to receive either 220 mg/d ZnSO4 or placebo for 8 weeks. Serum levels of Gal-3, lipid profile, and blood pressure (BP) were assessed at baseline and the end of trial. Results We found a significant effect of ZnSO4 intake on the reduction of serum Gal-3 (P = < 0.001), triglycerides (P = < 0.001), total cholesterol (P = < 0.001), low-density lipoprotein cholesterol (P = < 0.001) and increased high-density lipoprotein cholesterol (P = < 0.001) as compared to the control group. Additionally, systolic blood pressure (SBP) (P = 0.006) and diastolic blood pressure (DBP) (P = 0.01) were significantly reduced following 8 weeks of ZnSO4 supplementation. Conclusion Taken together, 220 mg ZnSO4 supplementation per day for 8 weeks among zinc-deficient DHPs had beneficial effects on Gal-3 and metabolic profiles. Iranian Registry of Clinical Trials Identifier IRCT20191217045765N1, date of registration: 2020–02-09.
- Open Access
- 19 January 2021
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 23 (1)
The Relationship Between Malnutrition and Liver Enzymes in Hospitalized Children in Zahedan: A Case-control Study
Background: Malnutrition causes nutritional, metabolism, and biochemical disorders and finally leads to mortality. Several studies have highlighted that serum liver enzymes are increased in patients with malnutrition. Objectives: This study aimed to evaluate the relationship between malnutrition and liver enzymes in hospitalized children in Zahedan. Methods: This case-control study was conducted among 145 hospitalized children under six years old, including 74 cases and 71 controls. The case group was diagnosed with malnutrition according to weight for age indices (Z-Score < -2SD), and controls were determined based on the following indices (Z-Score > -2SD) of classification of WHO 2006 growth standards. Serum was isolated after taking blood from the samples. Then liver enzymes, including AST, ALP, and ALT, were measured by spectrophotometric method. Results: A total of 145 subjects were enrolled that consisted of 74 cases and 71 controls. No significant difference was observed in serum liver markers, including AST, ALT, and ALP between the two groups, However, the level of AST, ALT, and ALP was higher than the standard level. There was a significant correlation between AST with ALT (r = 0.74, P < 0.001), and ALP (r = 0.27, P = 0.03). Conclusions: The findings indicated that there was no significant alteration in enzyme markers in the two groups. However, AST and ALT levels increased, and ALP levels decreased compared with the control. Different degrees of malnutrition, including mild, moderate, and severe, can probably change the levels of hepatic enzymes in under-nourished children. Alteration of these liver enzymes could be due to the metabolic modification, which can be the result of protein deficiency.
- 19 January 2021
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 23 (1)
Open AccessThe Relationship Between Malnutrition and Liver Enzymes in Hospitalized Children in Zahedan: A Case-control Study
Background: Malnutrition causes nutritional, metabolism, and biochemical disorders and finally leads to mortality. Several studies have highlighted that serum liver enzymes are increased in patients with malnutrition. Objectives: This study aimed to evaluate the relationship between malnutrition and liver enzymes in hospitalized children in Zahedan. Methods: This case-control study was conducted among 145 hospitalized children under six years old, including 74 cases and 71 controls. The case group was diagnosed with malnutrition according to weight for age indices (Z-Score < -2SD), and controls were determined based on the following indices (Z-Score > -2SD) of classification of WHO 2006 growth standards. Serum was isolated after taking blood from the samples. Then liver enzymes, including AST, ALP, and ALT, were measured by spectrophotometric method. Results: A total of 145 subjects were enrolled that consisted of 74 cases and 71 controls. No significant difference was observed in serum liver markers, including AST, ALT, and ALP between the two groups, However, the level of AST, ALT, and ALP was higher than the standard level. There was a significant correlation between AST with ALT (r = 0.74, P < 0.001), and ALP (r = 0.27, P = 0.03). Conclusions: The findings indicated that there was no significant alteration in enzyme markers in the two groups. However, AST and ALT levels increased, and ALP levels decreased compared with the control. Different degrees of malnutrition, including mild, moderate, and severe, can probably change the levels of hepatic enzymes in under-nourished children. Alteration of these liver enzymes could be due to the metabolic modification, which can be the result of protein deficiency.
- Open Access
- 13 October 2020
- Published by Brieflands in Annals of Military and Health Sciences Research
- Vol. 18 (3)
Evaluation of Oxidative Stress in Patients with Fracture Admitted to Khatam Al-Anbia Hospital in Zahedan
Background: Caused by an imbalance in the body’s oxidant and antioxidant status, oxidative stress can give rise to tissue damage and exacerbation of many diseases. Objectives: This study investigated the oxidative stress markers in patients with fractures and healthy subjects. Methods: In a cross-sectional case-control study, 40 patients with fractures admitted to an orthopedic ward and 40 healthy, non-fractured patients were selected using convenience sampling. Serum was analyzed for oxidant and antioxidant activities based on standard methods. P < 0.05 was considered statistically significant. Results: There was a significant difference in mean TAC between the case (748.2 ± 302.83 μmol/L) and control (984.90 ± 207.02 μmol/L) groups (P = 0.003). The mean MDA was 16.61 ± 4.16 µmol/L in the case group and 18.45 ± 5.43 µmol/L in the control group (P = 0.09). The mean SOD was 63.41 ± 16.67 U/g Hb in the case group and 58.54 ± 21.83 U/g Hb in the control group (P = 0.2). There was no significant difference between the two groups in terms of BMI and other variables. Conclusions: A significant difference existed in TAC between the two groups, which indicated increased oxidative stress in patients. However, oxidative stress could occur before and after undergoing fractures. The results suggested a slight, but not significant, difference between the two groups in the SOD and MDA scores. More conclusive results are required to determine the enzymatic and non-enzymatic markers of oxidative stress in larger sample sizes and during different stages of treatment.
- 13 October 2020
- Published by Brieflands in Annals of Military and Health Sciences Research
- Vol. 18 (3)
Open AccessEvaluation of Oxidative Stress in Patients with Fracture Admitted to Khatam Al-Anbia Hospital in Zahedan
Background: Caused by an imbalance in the body’s oxidant and antioxidant status, oxidative stress can give rise to tissue damage and exacerbation of many diseases. Objectives: This study investigated the oxidative stress markers in patients with fractures and healthy subjects. Methods: In a cross-sectional case-control study, 40 patients with fractures admitted to an orthopedic ward and 40 healthy, non-fractured patients were selected using convenience sampling. Serum was analyzed for oxidant and antioxidant activities based on standard methods. P < 0.05 was considered statistically significant. Results: There was a significant difference in mean TAC between the case (748.2 ± 302.83 μmol/L) and control (984.90 ± 207.02 μmol/L) groups (P = 0.003). The mean MDA was 16.61 ± 4.16 µmol/L in the case group and 18.45 ± 5.43 µmol/L in the control group (P = 0.09). The mean SOD was 63.41 ± 16.67 U/g Hb in the case group and 58.54 ± 21.83 U/g Hb in the control group (P = 0.2). There was no significant difference between the two groups in terms of BMI and other variables. Conclusions: A significant difference existed in TAC between the two groups, which indicated increased oxidative stress in patients. However, oxidative stress could occur before and after undergoing fractures. The results suggested a slight, but not significant, difference between the two groups in the SOD and MDA scores. More conclusive results are required to determine the enzymatic and non-enzymatic markers of oxidative stress in larger sample sizes and during different stages of treatment.
- Open Access
- 24 June 2020
- Published by Brieflands in Annals of Military and Health Sciences Research
- Vol. 18 (2)
The Prevalence of Metabolic Syndrome in Iranian Firefighters
Background: Metabolic syndrome (MetS) is closely related to the risk of cardiovascular disease (CVD), particularly in stressful occupations. Firefighting is a hazardous profession and is associated with high metabolic risk. However, limited studies on firefighters are available. Objectives: This study aimed to determine the prevalence of MetS among firefighters in Zahedan city, Iran. Methods: This cross-sectional study was performed on 140 firefighters (age range, 16 - 55 years) employed at the fire department in Zahedan city, southeast Iran. Anthropometric characteristics and metabolic risk parameters, including blood pressure (BP), fasting blood sugar (FBS), and lipid profile were measured, and the prevalence of metabolic syndrome was assessed based on National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. Results: MetS was presented in 47 (33.6%) of the firefighters. Among the metabolic risk factors, abdominal obesity (87.1%), low-high density lipoprotein (HDL-C) (62.1%), and hypertriglyceridemia (61.4%) were more prevalent. Moreover, a significant increasing trend was found with increasing age and work experience (both, P = 0.05). However, no significant differences were found for the remaining metabolic risk factors. Conclusions: The findings showed that about one-third of the firefighters had MetS. Age, abdominal obesity, and dyslipidemia were independent risk factors for MS in the firefighters. Thus, efforts should be undertaken to implement healthy lifestyle promotion programs for firefighters.
- 24 June 2020
- Published by Brieflands in Annals of Military and Health Sciences Research
- Vol. 18 (2)
Open AccessThe Prevalence of Metabolic Syndrome in Iranian Firefighters
Background: Metabolic syndrome (MetS) is closely related to the risk of cardiovascular disease (CVD), particularly in stressful occupations. Firefighting is a hazardous profession and is associated with high metabolic risk. However, limited studies on firefighters are available. Objectives: This study aimed to determine the prevalence of MetS among firefighters in Zahedan city, Iran. Methods: This cross-sectional study was performed on 140 firefighters (age range, 16 - 55 years) employed at the fire department in Zahedan city, southeast Iran. Anthropometric characteristics and metabolic risk parameters, including blood pressure (BP), fasting blood sugar (FBS), and lipid profile were measured, and the prevalence of metabolic syndrome was assessed based on National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. Results: MetS was presented in 47 (33.6%) of the firefighters. Among the metabolic risk factors, abdominal obesity (87.1%), low-high density lipoprotein (HDL-C) (62.1%), and hypertriglyceridemia (61.4%) were more prevalent. Moreover, a significant increasing trend was found with increasing age and work experience (both, P = 0.05). However, no significant differences were found for the remaining metabolic risk factors. Conclusions: The findings showed that about one-third of the firefighters had MetS. Age, abdominal obesity, and dyslipidemia were independent risk factors for MS in the firefighters. Thus, efforts should be undertaken to implement healthy lifestyle promotion programs for firefighters.